STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] PERRIGO Co plc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Perrigo (PRGO): T. Rowe Price Associates, Inc. filed Amendment No. 3 to Schedule 13G reporting beneficial ownership of 16,920,302 shares of common stock, representing 12.3% of the class as of 09/30/2025.

The filer reports sole voting power over 16,856,660 shares and sole dispositive power over 16,920,302 shares, with no shared voting or dispositive power. T. Rowe Price files as an investment adviser and states the securities were acquired and are held in the ordinary course, not to change or influence control.

Within the reported holdings, T. Rowe Price Mid-Cap Value Fund has an interest in 9,190,014 shares, equal to 6.7% of the class.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Associates, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/14/2025
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

1.92B
137.01M
0.41%
105.88%
5.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2